Skip to main content

Armstrong, Fleming & Moore, Inc

SEC CIK
0001990099
Latest filing
Jul 28, 2026

REGN holding history

Regeneron Pharmaceuticals, Inc. in every 13F filed by Armstrong, Fleming & Moore, Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

REGN overviewAll 13F holders of REGNFull Q2 2026 holdings

Shares (Q4 2024)
0
Sold out in Q4 2024
Value
$0
% of portfolio
0.0%
Quarters held
3
Since Q1 2024
Holdings of REGN by Armstrong, Fleming & Moore, Inc, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q4 20240$00.0%−209−100.0%Sold outHolders
Q3 2024209$219.7K0.1%00.0%UnchangedHolders
Q2 2024209$219.7K0.1%00.0%UnchangedHolders
Q1 2024209$201.2K0.1%+209NewHolders